Fundamental - Factsheet
Help
BARD1 LIFE SCIENCES LTD
BARD1 LIFE SCIENCES
Updated on 09 Apr 2021 (End of trading day)
Last (AUD): 3.470 |
Change: -0.040 |
High: 3.550 |
Change (%): -1.14 |
Low: 3.450 |
Open |
3.510 |
Yesterday's Close |
3.5100000000000002 |
Buy Price |
- |
Sell Price |
- |
Buy Volume (share) |
- |
Sell Volume (share) |
- |
Cumulative Volume (share) |
254,118 |
Cumulative Value |
|
Key Statistics
(AUD) a
|
-0.04064 |
(AUD) e |
-0.06178 |
(AUD) b |
0.4834 |
a
|
- |
f |
- |
b |
7.1783 |
(AUD) d
|
- |
Cash In Hand
(AUD) g |
0.0907 |
Issued & Paid-up Shares
c |
80,056,700 |
(%)
d
|
- |
Price / Cash In Hand
g |
38.258 |
Treasury Shares h |
- |
- 75
Daysi |
0.586 |
- 75
Days(%)i |
0.86 |
Market Cap (M) |
277.797 |
- 500
Daysi |
0.773 |
- 500 Days
(%)i |
0.11 |
Enterprise Value (M) |
271.953 |
|
1 |
Exchange Code |
BD1 |
Par Value (
AUD
)
|
n.a. |
52 Weeks Volatility (%) |
515.34 |
|
57.3 |
Sector & Industry |
Health Services
-
Medical/Nursing Services |
Notes:
-
Based on latest Full Year results announcement, adjusted for the current number of shares.
-
Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
-
-
Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
-
Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
-
Based on Trailing EPS.
-
Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
-
Rounded to the nearest thousand. Updated on 14 Jun 2016.
-
Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.
Peer Comparison
Type |
Name |
Market |
Market Cap (M)a |
b
|
c
|
d
|
(%)d
|
Reference |
BARD1 LIFE SCIENCES LTD |
ASX |
277.797 |
- |
- |
7.1783 |
- |
Industry |
Medical/Nursing Services
|
ASX |
1,592.253 |
63.353 |
28.119 |
2.4487 |
2.043 |
Local Peer |
SONIC HEALTHCARE |
ASX |
16,953.478 |
32.124 |
17.827 |
2.9083 |
2.382 |
Local Peer |
HEALIUS LTD |
ASX |
2,539.878 |
- |
- |
1.2657 |
0.637 |
Local Peer |
OCEANIA HEALTHCARE LTD |
ASX |
824.923 |
- |
- |
1.3263 |
2.474 |
Local Peer |
VIRTUS HEALTH LIMITED |
ASX |
509.672 |
1,087.479 |
33.031 |
1.7249 |
1.882 |
Local Peer |
CLOVER CORP |
ASX |
322.641 |
25.839 |
31.128 |
5.7721 |
1.289 |
Local Peer |
SILK LASER AUSTRALIA LTD |
ASX |
209.664 |
263.470 |
48.354 |
3.6253 |
- |
Local Peer |
HEALTHIA LTD |
ASX |
167.782 |
62.353 |
24.207 |
2.2119 |
0.751 |
Local Peer |
ORTHOCELL LIMITED |
ASX |
92.700 |
- |
- |
4.6490 |
- |
Local Peer |
TOTAL BRAIN LTD |
ASX |
31.408 |
- |
- |
1.4314 |
- |
Local Peer |
LIFESPOT HEALTH LTD |
ASX |
18.531 |
- |
- |
11.2245 |
- |
Local Peer |
MOHO RESOURCES NL |
ASX |
8.451 |
- |
- |
1.2674 |
- |
Local Peer |
SMILES INCLUSIVE LTD |
ASX |
- |
- |
- |
- |
- |
Global Peer |
JD HEALTH |
HKEx |
347,096.330 |
- |
- |
7.4584 |
- |
Global Peer |
FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV |
NYSE |
22,024.576 |
16.593 |
16.593 |
1.6050 |
- |
Global Peer |
GUARDANT HEALTH INC |
NASDAQ |
15,784.112 |
- |
- |
12.1557 |
- |
Global Peer |
OAK STREET HEALTH INC |
NYSE |
15,094.900 |
- |
- |
36.2700 |
- |
Global Peer |
PA GOODDOCTOR |
HKEx |
114,614.271 |
- |
- |
6.1054 |
- |
Global Peer |
DAVITA INC |
NYSE |
11,924.600 |
15.224 |
15.224 |
8.6187 |
- |
Global Peer |
AMEDISYS INC |
NASDAQ |
9,299.082 |
50.646 |
50.646 |
11.4914 |
- |
Global Peer |
NATERA INC |
NASDAQ |
9,051.691 |
- |
- |
18.6158 |
- |
Global Peer |
INVITAE CORP |
NYSE |
7,472.890 |
- |
- |
3.7813 |
- |
Global Peer |
CHEMED CORP |
NYSE |
7,461.231 |
23.355 |
23.355 |
8.2792 |
0.281 |
Other Global Peers |
LHC GROUP INC (NASDAQ), 1LIFE HEALTHCARE INC (NASDAQ), JXR (HKEx), NEOGENOMICS INC (NASDAQ), ACADIA HEALTHCARE (NASDAQ), ENSIGN GROUP INC (NASDAQ), SMILEDIRECTCLUB INC (NASDAQ), OPTION CARE HEALTH INC (NASDAQ), NH HEALTH-B (HKEx), BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A (NASDAQ), FULGENT GENETICS INC (NASDAQ), MEDNAX INC (NYSE), GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), CASTLE BIOSCIENCES INC (NASDAQ), ADDUS HOMECARE CORP (NASDAQ), US PHYSICAL THERAPY (NYSE), SVH (SET), PENNANT GROUP INC (NASDAQ), TIVITY HEALTH INC (NASDAQ), RADNET INC (NASDAQ), RAM (SET), KPJ (Bursa), APRIA INC (NASDAQ), UM HEALTHCARE (HKEx), HANGER INC (NYSE), Metro Healthcare Indonesia Tbk. (IDX), C-MER EYE (HKEx), FINCH THERAPEUTICS GROUP INC (NASDAQ), GLOBAL CORD BLOOD CORPORATION (NYSE), ONTRAK INC (NASDAQ), BIODESIX INC (NASDAQ), EUROEYES (HKEx), CARDIFF ONCOLOGY INC (NASDAQ), TOWN HEALTH (HKEx), GLOBAL X FDS ARTIFICIAL INTELLIGENCE AND TECH ETF (NASDAQ), CRH MEDICAL CORP (NYSE American), EXAGEN INC (NASDAQ), SANARA MEDTECH INC (NASDAQ), PROGENITY INC (NASDAQ), AKUMIN INC (NASDAQ), ONCOSEC MEDICAL INCORPORATED (NASDAQ), APTINYX INC (NASDAQ), OPTINOSE INC (NASDAQ), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), GREENBROOK TMS INC (NASDAQ), KANGHUA HEALTH (HKEx), CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) (NYSE), OPTIMAX (Bursa), PRO-DEX INC (NASDAQ), RAILY AESMED (HKEx), UMP (HKEx), CAPITAL SENIOR LIVING CORP (NYSE), Clearbridge (SGX), Cordlife (SGX), Diagnos Laboratorium Utama Tbk. (IDX), NOVO INTEGRATED SCIENCES INC (NASDAQ), GBS INC (NASDAQ), Asian Healthcare (SGX), BIOCEPT INC (NASDAQ), MHCARE (Bursa), GUARDION HEALTH SCIENCES INC (NASDAQ), KDH (SET), HC Surgical (SGX), HUMAN HEALTH (HKEx), IMAC HOLDINGS INC (NASDAQ), D (SET), CHINA HEALTH (HKEx), Alliance HC (SGX), Sing Paincare (SGX), RMH HOLDINGS (HKEx), Medinex (SGX), AsiaMedic (SGX), WAH YAN-OLD (HKEx), WAH YAN-NEW (HKEx), SMILE (Bursa), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), RHT HealthTrust (SGX), REPUBLIC HC (HKEx), MEDINET GROUP (HKEx) |
Notes:
-
For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is
the average market cap for that industry/index.
-
Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the
industry/index.
-
Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all
companies in the industry/index.
-
Industry/Index Dividend Yield is
calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
-
For Industry/Index calculation, data for foreign currency denominated companies will be converted to the
main market currency using the latest exchange rate.
-
Industry/Index/Peers data is updated daily.
-
Peers are sorted by market capitalisation and only details for the top 10 will be shown.
Total Shareholder Return
Period | Dividend Received | Capital Appreciation | Total Shareholder Return |
---|
Short Term Return |
5 Days |
- | -0.160 | | | -4.41 % |
10 Days |
- | -0.300 | | | -7.96 % |
20 Days |
- | -0.520 | | | -13.03 % |
Medium Term Return |
3 Months |
- | +2.870 | | | +478.33 % |
6 Months |
- | +2.690 | | | +344.87 % |
1 Year |
- | +2.690 | | | +344.87 % |
Long Term Return |
2 Years |
- | +2.875 | | | +483.19 % |
3 Years |
- | +2.975 | | | +601.01 % |
Annualised Return |
Annualised |
- | - | | | +91.39 % |
Notes:
-
Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
-
Script dividends are ignored in this calculation.
Price Movements
1 Year Range |
0.021 - 5.600 |
Change From 1 Year Low |
+3.449 |
% Change From 1 Year Low (%) |
+16423.81 |
Change From 1 Year High |
-2.130 |
% Change From 1 Year High (%) |
-38.04 |
2 Years Range |
0.021 - 5.600 |
Change From 2 Years Low |
+3.449 |
% Change From 2 Years Low (%) |
+16423.81 |
Change From 2 Years High |
-2.130 |
% Change From 2 Years High (%) |
-38.04 |
5 Years Range |
0.021 - 5.600 |
Change From 5 Years Low |
+3.449 |
% Change From 5 Years Low (%) |
+16423.81 |
Change From 5 Years High |
-2.130 |
% Change From 5 Years High (%) |
-38.04 |
Notes:
Price movements are based on adjusted historical data.
Company Background
BARD1 Life Sciences Ltd. is a biotechnology company, which engages in the provision of medical services. Its activities include research and development of non-invasive diagnostic tests for early detection of cancer, based on certain proprietary intellectual property. The company was founded on June 30, 1983 and is headquartered in Subiaco, Australia.
More Information Available
More information is available to our subscribers, including:
- Market Moving News from Dow Jones Newswires
- Consensus Estimates
- Dividend/Distribution History
- Financial Summary with Financial Period Comparison
- Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
- Events Calendar for Results Announcements, Ex-Dates etc
- Insider Buying and Selling Report
If you are an existing subscriber, please login. If not, read up on what
you are missing out in our Help Centre
and join us as a subscriber.
Disclaimer:
While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-
- no liability is accepted for any errors or inaccuracies resulting from your use of these features;
- many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.